Strata Critical Medical (SRTA) Depreciation & Amortization (CF) (2021 - 2026)

Strata Critical Medical (SRTA) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $3.1 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $3.1 million, up 80.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.5 million (up 57.43% YoY), and the FY2025 annual result was $8.2 million, up 37.29% from the prior year.
• Depreciation & Amortization (CF) advanced to $3.1 million in Q1 2026 per SRTA's latest filing, from $3.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $3.1 million in Q1 2026 and troughed at $1.1 million in Q1 2022.
• A 5-year average of $1.9 million and a median of $1.7 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) soared 808.73% in 2022, then slumped 30.6% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.3 million in 2022, then decreased by 21.48% to $1.8 million in 2023, then fell by 15.28% to $1.5 million in 2024, then soared by 96.6% to $3.0 million in 2025, then grew by 1.73% to $3.1 million in 2026.
• Business Quant data shows SRTA's Depreciation & Amortization (CF) at $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $1.7 million in Q3 2025.